A detailed history of Burleson & Company, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Burleson & Company, LLC holds 24,229 shares of JNJ stock, worth $3.54 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares
24,229
Previous 16,286 48.77%
Holding current value
$3.54 Million
Previous $2.66 Million 60.9%
% of portfolio
1.12%
Previous 0.57%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 30, 2023

BUY
$160.2 - $179.79 $1.27 Million - $1.43 Million
7,943 Added 48.77%
24,229 $4.28 Million
Q3 2022

Oct 17, 2022

BUY
$161.33 - $179.52 $195,854 - $217,937
1,214 Added 8.05%
16,286 $2.66 Million
Q2 2022

Jul 13, 2022

SELL
$168.19 - $186.01 $1,177 - $1,302
-7 Reduced 0.05%
15,072 $2.68 Million
Q1 2022

Apr 25, 2022

BUY
$158.14 - $179.59 $16,130 - $18,318
102 Added 0.68%
15,079 $2.67 Million
Q4 2021

Jan 25, 2022

SELL
$155.93 - $173.01 $11,382 - $12,629
-73 Reduced 0.49%
14,977 $2.56 Million
Q3 2021

Nov 02, 2021

SELL
$161.5 - $179.47 $62,500 - $69,454
-387 Reduced 2.51%
15,050 $2.43 Million
Q2 2021

Jul 22, 2021

SELL
$159.48 - $171.07 $65,067 - $69,796
-408 Reduced 2.57%
15,437 $2.54 Million
Q1 2021

May 12, 2021

SELL
$153.07 - $170.48 $83,576 - $93,082
-546 Reduced 3.33%
15,845 $2.6 Million
Q4 2020

Feb 08, 2021

SELL
$137.11 - $157.38 $2,056 - $2,360
-15 Reduced 0.09%
16,391 $2.58 Million
Q3 2020

Nov 10, 2020

BUY
$140.38 - $153.83 $1,544 - $1,692
11 Added 0.07%
16,406 $2.33 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $34,005 - $41,054
264 Added 1.64%
16,395 $2.44 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $231,949 - $321,377
-2,087 Reduced 11.46%
16,131 $2.4 Million
Q4 2019

Feb 12, 2020

BUY
$127.5 - $146.44 $510 - $585
4 Added 0.02%
18,218 $2.7 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $634 - $710
5 Added 0.03%
18,214 $2.37 Million
Q2 2019

Aug 05, 2019

BUY
$131.15 - $144.24 $524 - $576
4 Added 0.02%
18,209 $2.37 Million
Q1 2019

May 09, 2019

BUY
$125.72 - $139.79 $233,210 - $259,310
1,855 Added 11.35%
18,205 $2.59 Million
Q4 2018

Feb 27, 2019

SELL
$122.84 - $147.84 $3,562 - $4,287
-29 Reduced 0.18%
16,350 $2.21 Million
Q3 2018

Dec 06, 2018

BUY
$121.58 - $142.88 $45,349 - $53,294
373 Added 2.33%
16,379 $2.42 Million
Q2 2018

Jul 31, 2018

BUY
$119.4 - $131.76 $609,417 - $672,503
5,104 Added 46.82%
16,006 $1.94 Million
Q1 2018

Apr 23, 2018

BUY
$125.1 - $148.14 $625 - $740
5 Added 0.05%
10,902 $1.4 Million
Q4 2017

Mar 19, 2018

BUY
$131.22 - $143.62 $1.43 Million - $1.57 Million
10,897
10,897 $1.52 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $382B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Burleson & Company, LLC Portfolio

Follow Burleson & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.